3,4-dihydroxyphenylethanol has been researched along with Cirrhosis, Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alisi, A; Bianchi, M; Braghini, MR; Comparcola, D; Condorelli, AG; Conti, LA; Crudele, A; De Stefanis, C; Gurrado, F; Lioci, G; Mosca, A; Nobili, R; Panera, N; Sartorelli, MR; Scoppola, V; Smeriglio, A; Svegliati-Baroni, G; Trombetta, D | 1 |
| Carpi, S; Carrara, M; Cazzagon, N; Colognesi, M; De Martin, S; Digiacomo, M; Gabbia, D; Guido, M; Macchia, M; Nieri, P; Polini, B; Russo, FP; Sarcognato, S; Sayaf, K; Zanotto, I | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylethanol and Cirrhosis, Liver
| Article | Year |
|---|---|
Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis.
Topics: Animals; Carbon Tetrachloride; Fibrosis; Liver; Liver Cirrhosis; Mice; Non-alcoholic Fatty Liver Disease; Phenylethyl Alcohol; Reactive Oxygen Species; Transcription Factors; Transforming Growth Factor beta; Vitamin E | 2022 |
The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Mice; MicroRNAs; NADPH Oxidases; Oxidative Stress | 2023 |